General Information of the Molecule (ID: Mol01068)
Name
Ribonuclease PH (RPH) ,Listeria monocytogenes
Synonyms
RNase PH; tRNA nucleotidyltransferase; LMOf2365_1247
    Click to Show/Hide
Molecule Type
Protein
Gene Name
rph
Sequence
MRVDGRESNALRNIEVTPDYLMHPEGSVLIASGNTKVICSASVETKVPPFMRGEGRGWIS
AEYSMLPRATNTRNIRESSKGKVTGRTMEIQRLIGRALRAVVDLDALGERTIWLDCDVIQ
ADGGTRTASITGAFIAMVMAIAKLDEAVPFAKFPVKDFLAATSVGVLEEGGTVLDLNYVE
DSAAQVDMNIIMTGSGAFVELQGTGEEATFSETELAELIALGKKGISELIEIQKETLGDK
VTARIKGE
    Click to Show/Hide
Function
Phosphorolytic 3'-5' exoribonuclease that plays an important role in tRNA 3'-end maturation. Removes nucleotide residues following the 3'-CCA terminus of tRNAs; can also add nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates, but this may not be physiologically important. Probably plays a role in initiation of 16S rRNA degradation (leading to ribosome degradation) during starvation.
    Click to Show/Hide
Uniprot ID
RNPH_LISMF
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Listeriaceae
Genus: Listeria
Species: Listeria monocytogenes
Type(s) of Resistant Mechanism of This Molecule
  DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Click to Show/Hide the Full List of Drugs
Rifampin
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Drug Inactivation by Structure Modification (DISM) Click to Show/Hide
Disease Class: HIV-infected patients with tuberculosis [1], [2], [3]
Resistant Disease HIV-infected patients with tuberculosis [ICD-11: 1C60.0]
Resistant Drug Rifampin
Molecule Alteration Expression
Up-regulation
Experimental Note Identified from the Human Clinical Data
In Vitro Model Escherichia coli TOP10 83333
Bacillus cereus RPH-Bc 1396
Escherichia coli Rosetta(DE3) pLysS 866768
L. monocytogenes 1639
Experiment for
Molecule Alteration
Whole genome sequence assay
Experiment for
Drug Resistance
MIC assay
Mechanism Description RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation.
Rifaximin
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Drug Inactivation by Structure Modification (DISM) Click to Show/Hide
Disease Class: MycoBacterial infection [1], [2], [3]
Resistant Disease MycoBacterial infection [ICD-11: 1B2Z.1]
Resistant Drug Rifaximin
Molecule Alteration Expression
Up-regulation
Experimental Note Identified from the Human Clinical Data
In Vitro Model Escherichia coli TOP10 83333
Bacillus cereus RPH-Bc 1396
Escherichia coli Rosetta(DE3) pLysS 866768
L. monocytogenes 1639
Experiment for
Molecule Alteration
Whole genome sequence assay
Experiment for
Drug Resistance
MIC assay
Mechanism Description RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation.
References
Ref 1 A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria. Proc Natl Acad Sci U S A. 2014 May 13;111(19):7102-7. doi: 10.1073/pnas.1402358111. Epub 2014 Apr 28.
Ref 2 Rifampin phosphotransferase is an unusual antibiotic resistance kinase. Nat Commun. 2016 Apr 22;7:11343. doi: 10.1038/ncomms11343.
Ref 3 Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J Antimicrob Chemother. 1994 Jun;33(6):1127-35. doi: 10.1093/jac/33.6.1127.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.